We are live on ! Find out more
OXFD

Oxford Immunotec Global
OXFD

Delisted

OXFD was delisted on the 5th of March, 2021.

65 hedge funds and large institutions have $225M invested in Oxford Immunotec Global in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 30 increasing their positions, 23 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 23

0.46% more ownership

Funds ownership: 92.07% → 92.53% (+0.46%)

7% less capital inflows, than outflows

Capital inflows: $36.4M | Capital outflows: $39.3M

4% less funds holding

Funds holding: 68 → 65 (-3)

33% less funds holding in top 10

Funds holding in top 10: 6 → 4 (-2)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

Holders
65
Holders Change
-3
Holders Change %
-4.41%
% of All Funds
1.43%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.09%
New
4
Increased
30
Reduced
23
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

OXFD Hedge Fund Activity: Q1 2020 in Review

65 of the 4,552 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global (OXFD) for Q1 2020, worth a combined $225M — down 44% from $404M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of OXFD and 4 opened new positions — a net loss of 3 holders — while 23 trimmed existing stakes and 30 added.

The largest buyer was Senvest Management, adding an estimated $8.75M. The largest seller was Consonance Capital Management, cutting an estimated $15.6M.

  • 65 institutional investors held Oxford Immunotec Global (OXFD) as of Q1 2020, down from 68 in Q4 2019.
  • Funds reported $225M of Oxford Immunotec Global stock for Q1 2020, down 44% quarter-over-quarter.
  • 4 funds opened new Oxford Immunotec Global positions in Q1 2020 and 7 closed out, a net change of -3 holders.
  • The largest Oxford Immunotec Global buyer in Q1 2020 was Senvest Management, an estimated $8.75M added.
  • The largest Oxford Immunotec Global seller in Q1 2020 was Consonance Capital Management, an estimated $15.6M sold.

Based on aggregated 13F filings for Q1 2020.